SCHEMBL7105089

SCHEMBL7105089

CCNC(=O)c1cn(Cc2cccc(C#N)c2)cc1Cc1ccc(C#N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 4/20 0.46
KLK1 P06870 2/20 0.46
GRIN1 Q05586 3/20 0.45
GRIN2A Q12879 3/20 0.45
GRIA2 P42262 1/20 0.45
BRD4 O60885 1/20 0.42
CYP19A1 P11511 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
GLS O94925 1/20 0.39
ADRA1D P25100 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.38
SIRT1 Q96EB6 1/20 0.38
ERCC1 P07992 1/20 0.38
ERCC4 Q92889 1/20 0.38
SNCA P37840 2/20 0.37
ROCK2 O75116 1/20 0.37
FAAH O00519 1/20 0.37
CLPP Q16740 1/20 0.37
FASN P49327 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164552 0.91 BRD4 (0.50) KLKB1KLK1BRD4CYP19A1CYP11B1
SCHEMBL6181404 0.88 KLKB1 (0.44) KLKB1KLK1GRIN1GRIN2AGRIA2
SCHEMBL6163869 0.86 POLB (0.45) KLKB1KLK1CYP19A1CYP11B1CYP11B2
SCHEMBL7101526 0.85 CYP19A1 (0.43) KLKB1KLK1BRD4CYP19A1CYP11B1
SCHEMBL7105122 0.84 KLKB1 (0.39) KLKB1KLK1BRD4CYP19A1CYP11B1
SCHEMBL6166642 0.84 KLKB1 (0.42) KLKB1KLK1GRIN1GRIN2AGRIA2
SCHEMBL6165929 0.84 ADRA1D (0.52) KLKB1KLK1BRD4CYP19A1CYP11B1
SCHEMBL7106232 0.83 CYP11B1 (0.43) KLKB1KLK1GRIN1GRIN2AGRIA2
SCHEMBL7102332 0.83 KLKB1 (0.39) KLKB1KLK1GRIN1GRIN2AGRIA2
SCHEMBL6164249 0.82 POLB (0.40) KLKB1KLK1BRD4CYP19A1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof LG CHEM INVESTMENT LTD. (KR) 2003-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof F2, F12, TFPI KLKB1 530/4885KLK1 692/4885GRIN1 4084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.